MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

No Stability Information

Zinc citrate 50mg capsules (Special Order)

Explore other Zinc citrate formulations Explore other Zinc citrate 50mg capsules suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Zinc citrate 50mg capsules (Vega Nutritionals Ltd)

Explore other Zinc citrate formulations Explore other Zinc citrate 50mg capsules suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Zinc oxide 15% and Ichthammol 1% in Yellow soft paraffin (Drug Tariff Special Order)

Explore other Ichthammol + Zinc oxide formulations Explore other Zinc oxide 15% and Ichthammol 1% in Yellow soft paraffin suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Zinc oxide 15% in Yellow soft paraffin (Special Order)

Explore other Zinc oxide formulations Explore other Zinc oxide 15% in Yellow soft paraffin suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Zinc sulfate 1% lotion (Special Order)

Explore other Zinc sulfate formulations Explore other Zinc sulfate 1% lotion suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Zinc sulfate 50mg capsules (Special Order)

Explore other Zinc sulfate formulations Explore other Zinc sulfate 50mg capsules suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Zinc sulfide lotion BPC 1979 (Special Order)

Explore other Camphor + Sulfurated potash + Zinc sulfate formulations Explore other Zinc sulfide lotion BPC 1979 suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

ZincoPhate 220mg capsules (Essential-Healthcare Ltd)

Explore other Zinc sulfate formulations Explore other Zinc sulfate 220mg capsules suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Zindole 220mg capsules (TriOn Pharma Ltd)

Explore other Zinc sulfate formulations Explore other Zinc sulfate 220mg capsules suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Zineryt lotion (CST Pharma Ltd)

Explore other Erythromycin + Zinc acetate formulations Explore other Erythromycin 40mg/ml / Zinc acetate 12mg/ml lotion suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Zineryt lotion (Lexon (UK) Ltd)

Explore other Erythromycin + Zinc acetate formulations Explore other Erythromycin 40mg/ml / Zinc acetate 12mg/ml lotion suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Zineryt lotion (Necessity Supplies Ltd)

Explore other Erythromycin + Zinc acetate formulations Explore other Erythromycin 40mg/ml / Zinc acetate 12mg/ml lotion suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Zineryt lotion (Sigma Pharmaceuticals Plc)

Explore other Erythromycin + Zinc acetate formulations Explore other Erythromycin 40mg/ml / Zinc acetate 12mg/ml lotion suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Zing 220mg capsules (Ennogen Healthcare International Ltd)

Explore other Zinc sulfate formulations Explore other Zinc sulfate 220mg capsules suppliers

Stability Notes

There are no stability notes available for this medicine.

Use with caution

Zinnat 250mg tablets (CST Pharma Ltd)

Explore other Cefuroxime formulations Explore other Cefuroxime 250mg tablets suppliers

Stability Notes

Protect from light. Store in airtight container.

Provenance

This compatibility recommendation is derived from Zinnat 250mg tablets (Sandoz Ltd).

Print this list

Compatible

Medicines suitable for use in MCAs, although use is likely to be off-label.  Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed).  Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices.  Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Use with caution

There are concerns about stability and/or there is a lack of stability data available. These medicines can theoretically be used in MCAs, although use is likely to be off-label.  Mitigation measures may need to be considered.  Keep medicines in MCAs for the shortest time necessary.  Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed). Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices. Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Incompatible

Medicines under this category are not suitable for use in MCAs.

No Stability Information

These medicines have not been reviewed by SPS.